1. Home
  2. AMPL vs SPRY Comparison

AMPL vs SPRY Comparison

Compare AMPL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$6.40

Market Cap

914.7M

Sector

Technology

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.75

Market Cap

823.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPL
SPRY
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
914.7M
823.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AMPL
SPRY
Price
$6.40
$8.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
1
Target Price
$13.42
$40.00
AVG Volume (30 Days)
1.9M
1.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
11.84
N/A
EPS
N/A
N/A
Revenue
$343,214,000.00
$84,278,000.00
Revenue This Year
$17.43
$87.40
Revenue Next Year
$14.16
$81.64
P/E Ratio
N/A
N/A
Revenue Growth
14.68
N/A
52 Week Low
$5.51
$6.66
52 Week High
$14.27
$18.63

Technical Indicators

Market Signals
Indicator
AMPL
SPRY
Relative Strength Index (RSI) 43.31 53.70
Support Level $5.75 $8.61
Resistance Level $7.73 $9.46
Average True Range (ATR) 0.42 0.49
MACD -0.06 0.11
Stochastic Oscillator 29.87 53.39

Price Performance

Historical Comparison
AMPL
SPRY

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: